Skip to main content

Clinical

RSS  

Articles

  • ECG Review: Chest Pain in a 21 Year Old

    Clinical Scenario: The ECG in the Figure shows normal sinus rhythm at a rate of 80 beats/minute. The PR, QRS, and QT intervals are normal. There is an rSR pattern in lead III. The axis is +40°. There is no sign of chamber enlargement. The most remarkable finding on this tracing is the presence of subtle but real ST segment elevation in multiple leads including I, II, aVF, and V2 through V6.
  • Pharmacology Watch: Smallpox Vaccination Guidelines Published by CDC

    Smallpox Vaccination Guidelines Published by CDC; Nurses: Delay Vaccination Program; Viagra Effective for Depression Treatment; Finisteride/Doxazosin no Better than Placebo for Urinary Obstruction; Serevent Receives Dear Doctor Letter
  • Moderation In All Things, Even Sleep

    Women who habitually sleep 5 or fewer or 9 or more hours per night have an increased risk of coronary heart disease compared with those who sleep 7 or 8 hours a night.
  • Pharmacology Update: Alefacept (Amevive) for Psoriasis Treatment

    Alefacept is a new biological agent for the treatment of moderate-to-severe plaque psoriasis. The drug, which targets T lymphocytes, is a fusion protein combining the binding site of lymphocyte function-associated antigen-3 and the Fc portion of human IgG1.
  • Clinical Briefs in Primary Care

    Ice Cream-Evoked Headaches Study: A Randomized Trial of Accelerated vs Cautious Eating; Treatment of Antidepressant-Associated Sexual Dysfunction with Sildenafil; Prophylactic Treatment of Migraine with an Angiotensin II Receptor Blocker; Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients; ACE + ARB for Diabetic and Hypersensitive Neuropathy; Action and Efficacy of a Combination of Calcipotriene and Betamethasone Dipropionate in the Treatment of Psoriasis
  • Maintain confidential care for adolescents

    Your practice includes confidential care for adolescents, including provision of contraceptives and testing/treatment for sexually transmitted diseases (STDs). But are your office staff communicating the confidentiality of this information correctly to prospective teen patients? If they are not, adolescents may fail to access these important services.
  • The Pill and bone health: What is the impact?

    Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?
  • Ask the Experts: Answers to questions on OC use, DMPA impact

    Whats the impact of concomitant medications on combined oral contraceptives (OCs)?
  • CTU Updates

    Enter abstracts for ARHP annual conference; New payment options announced for Mirena
  • Hormone therapy: Make decisions on a balanced risk-to-benefit basis

    Family planning clinicians have found their care of postmenopausal women has changed dramatically since the July 2002 cessation of the estrogen/progestin arm of the Womens Health Initiative (WHI). The estrogen/progestin arm of the landmark study was halted after findings showed that the overall health risk, particularly of cardiovascular disease and breast cancer, from taking estrogens with progestin was greater than the benefits of lowering the risk of colon cancer and bone fractures.